Kimberley S. Samkoe

Overview

Kimberley Samkoe is an associate professor of engineering at Dartmouth and was previously an assistant research professor in the Department of Surgery at Geisel School of Medicine. Dr. Samkoe’s current research interests involve molecular fluorescence imaging for quantitative assessment of in vivo molecular expression of proteins for cancer diagnosis, therapeutic monitoring and surgical resection. Her research takes a biological systems engineering approach to medical imaging by studying how microscopic molecular information can be interpreted at a macro-scale for cancer identification and diagnosis. Other research interests include photodynamic therapy, spectroscopy, and the physical chemistry of fluorescent molecules.

Research Interests

Quantitative fluorescence molecular imaging; fluorescence guided surgery; biomedical systems engineering; biological models of cancer; cancer diagnostics and therapeutic monitoring; optics in medicine; photodynamic therapy

Education

BSc, biochemsitry, University of Regina 2001
PhD, biophysical chemistry, University of Calgary 2007

Awards

Faculty Research Award, Department of Surgery, Dartmouth-Hitchcock, 2019–2020
R37 Method to Extend Research in Time (MERIT) Award, National Cancer Institute, 2018–present
Harmes Scholar, Department of Surgery, Dartmouth-Hitchcock, 2014–2016
Michael Lazar Community Service Award, Faculty of Graduate Studies, University of Calgary, 2006
Alberta Ingenuity Fund Incentive Award, 2002–2007
NSERC-eMPOWR Award, Natural Sciences and Engineering Research Council (NSERC) of Canada, 2002–2005

Professional Activities

Member, American Society for Photobiology
Selected Journal Reviewer: Photochemistry and Photobiology, Journal of Applied Physics, Photodiagnosis and Photodynamic Therapy, International Journal of Radiation Oncology Biology Physics

Research Projects

Optical molecular imaging

Optical molecular imaging

Optical molecular imaging is being used to provide molecular guidance in cancer surgery. Fluorescent contrast agents are in pre-clinical and clinical studies to image cancer tumors in vivo, with a dual focus, first on getting more accurate information out of the tissue, and secondly to provide better information about the specificity of the molecules as markers. Systems and algorithms for diffuse fluorescence imaging of tissue are studied, both as a stand-alone system, and as coupled to magnetic resonance imaging and computed tomography imaging. Tracer kinetic modeling is also being developed to allow quantitative imaging of molecular binding in vivo.
Fluorescence-guided surgery

Fluorescence-guided surgery

Fluorescence-guided surgery is important for the resection of some types of cancerous tumors where the tumor and normal tissue are similar in appearance and texture, and patient prognosis depends heavily on the completeness of resection. By selectively tagging tumor tissue with fluorescent dyes, it becomes possible to visually discriminate between normal and tumor tissues and improve significantly the completeness of tumor resection.
Photodynamic therapy

Photodynamic therapy

Photodynamic therapy (PDT) is a newly emerging therapy for displastic tissues, such as cancer, age-related blindness, pre-malignant transformation or psoriasis. The therapy involves the administration of a photosensitizing agent, together with the application of moderate intensity light to active the molecules to produce local doses of singlet oxygen. Ongoing research topics include, developing improved dosimetry instrumentation and software, fluorescence tomography imaging to sense drug localization, and assaying unique tumor biology and treatment effects in experimental cancers.

Selected Publications

Samkoe KS, Sardar HS, Bates BD, et al. Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection. J Surg Oncol. 2019;119(8):1077‐1086. doi:10.1002/jso.25468
Samkoe KS, Gunn JR, Marra K, et al. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use. Mol Imaging Biol. 2017;19(4):512‐521. doi:10.1007/s11307-016-1033-y
DSouza AV, Lin H, Henderson ER, Samkoe KS, Pogue BW. Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt. 2016;21(8):80901. doi:10.1117/1.JBO.21.8.080901
Tichauer KM, Samkoe KS, Gunn JR, et al. Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging. Nat Med. 2014;20(11):1348‐1353. doi:10.1038/nm.3732
Samkoe KS, Tichauer KM, Gunn JR, Wells WA, Hasan T, Pogue BW. Quantitative in vivo immunohistochemistry of epidermal growth factor receptor using a receptor concentration imaging approach. Cancer Res. 2014;74(24):7465‐7474. doi:10.1158/0008-5472.CAN-14-0141
Samkoe KS, Bryant A, Gunn JR, Pereira SP, Hasan T, Pogue BW. Contrast enhanced-magnetic resonance imaging as a surrogate to map verteporfin delivery in photodynamic therapy. J Biomed Opt. 2013;18(12):120504. doi:10.1117/1.JBO.18.12.120504
Davis SC, Samkoe KS, Tichauer KM, et al. Dynamic dual-tracer MRI-guided fluorescence tomography to quantify receptor density in vivo. Proc Natl Acad Sci U S A. 2013;110(22):9025‐9030. doi:10.1073/pnas.1213490110
Tichauer KM, Samkoe KS, Sexton KJ, et al. In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging. Mol Imaging Biol. 2012;14(5):584‐592. doi:10.1007/s11307-011-0534-y
Samkoe KS, Chen A, Rizvi I, et al. Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models. Int J Radiat Oncol Biol Phys. 2010;76(1):251‐259. doi:10.1016/j.ijrobp.2009.08.041
Samkoe KS, Clancy AA, Karotki A, Wilson BC, Cramb DT. Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: implications for treatment of wet age-related macular degeneration. J Biomed Opt. 2007;12(3):034025. doi:10.1117/1.2750663